<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02607462</url>
  </required_header>
  <id_info>
    <org_study_id>PRP THA 092015</org_study_id>
    <nct_id>NCT02607462</nct_id>
  </id_info>
  <brief_title>PRP Therapy to m. Gluteus Medius During THA</brief_title>
  <official_title>Single Injection of Platelet-rich Plasma (PRP) to m. Gluteus Medius During Total Hip Arthroplasty Using Direct Lateral (Hardinge) Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Satakunta Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Satakunta Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study purpose is to evaluate perioperative usefulness of Platelet-rich Plasma (PRP) in total
      hip arthroplasty (THA) surgery. The study is designed as a randomized double blinded study
      using saline as placebo. The measurement outcomes includes objective variables (MRI,
      dynamometer) as well as subjective measurements (Oxford Hip Score, Harris Hip Score).

      Patients are assigned to two different groups, according to a randomization list. PRP
      (approximately 9ml from which 1ml is delivered to in-house laboratory for the measurement of
      platelet count) is obtained from venous blood and applied to m. gluteus medius during the
      closure of modified lateral approach (Hardinge).

      Study participants are evaluated preoperatively by trained physiotherapist. After surgery,
      participants undergo clinical evaluation and imaged (MRI) at 3 and 12 months post-operative.
      In the same time points, strength, Harris Hip Score and Oxford Hip Score. At the end of the
      study, the nature of the injected substance is revealed to the patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2015</start_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The decrease of T2 weighted signaling between PRP and placebo group</measure>
    <time_frame>Change from 3 months at 12 months</time_frame>
    <description>Quantitative method of tissue healing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in Harris Hip Score points between PRP and placebo group</measure>
    <time_frame>Change from 3 months at 12 months</time_frame>
    <description>Quality method of post-operative healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of hip abduction strengths between PRP and placebo group using dynamometer</measure>
    <time_frame>Change from 3 months at 12 months</time_frame>
    <description>Quantitive method of abduction strengths</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>PRP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Platelet-rich plasma taken made from centrifuged venous blood.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sodium chloride 0.9% used as placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PRP</intervention_name>
    <arm_group_label>PRP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically and radiology confirmed arthritis which treatment is total hip
             arthroplasty.

        Exclusion Criteria:

          -  Revision surgery, insulin dependent diabetes and other endocrinology disease, smoking,
             use of per os cortisone, malignancy, rheumatoid arthritis, any autoimmune disease,
             alcoholist, previous fracture to hip, patients with diagnosed mental illness, absolute
             contraindications for MRI study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jussi Kosola, MD, PhD</last_name>
    <phone>+358442607366</phone>
    <email>jussi.kosola@helsinki.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juha Kukkonen, MD, PhD</last_name>
    <phone>+358505330095</phone>
    <email>juha.kukkonen@utu.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Satakunta Central Hospital</name>
      <address>
        <city>Pori</city>
        <zip>28500</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jussi Kosola, MD, PhD</last_name>
      <phone>+358 44 2607 366</phone>
      <email>jussi.kosola@utu.fi</email>
    </contact>
    <contact_backup>
      <last_name>Juha Kukkonen, MD, PhD</last_name>
      <phone>+ 258 50 533 0095</phone>
      <email>juha.kukkonen@utu.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2015</study_first_submitted>
  <study_first_submitted_qc>November 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>April 15, 2016</last_update_submitted>
  <last_update_submitted_qc>April 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Satakunta Central Hospital</investigator_affiliation>
    <investigator_full_name>Jussi Kosola</investigator_full_name>
    <investigator_title>Resident, researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

